cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Krystal Biotech Inc
4 own
8 watching
Current Price
$80.36
$0.41
(0.51%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,066.03M
52-Week High
52-Week High
85.65
52-Week Low
52-Week Low
47.67
Average Volume
Average Volume
0.12M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,066.03M
icon52-Week High85.65
icon52-Week Low47.67
iconAverage Volume0.12M
iconDividend Yield--
iconP/E Ratio--
What does the Krystal Biotech Inc do?
N/A
Read More
How much money does Krystal Biotech Inc make?
News & Events about Krystal Biotech Inc.
Globe Newswire
30days ago
NEW PDUFA DATE OF MAY 19, 2023PITTSBURGH, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the Company) (NASDAQ: KRYS) today announced that on January 5, 2023, the U.S. Food and Drug Administration(FDA) notified the Company that based on manufacturing information submitted to the Agency on ...
Ticker Report
1month ago
Krystal Biotech, Inc. (NASDAQ:KRYS Get Rating) insider Suma Krishnan sold 1,700 shares of the firms stock in a transaction on Tuesday, January 3rd. The stock was sold at an average price of $80.33, for a total value of $136,561.00. Following the sale, the insider now directly owns 1,...
Globe Newswire
2 months ago
PITTSBURGH, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the Company) (NASDAQ: KRYS) a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases, announced today that the Company will participate in the Evercore ISI 5th Annual ...
Zolmax
9 months ago
Krystal Biotech (NASDAQ:KRYS Get Rating) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research note issued on Thursday, Zacks.com reports. The firm presently has a $71.00 price target on the stock. Zacks Investment Researchs price objective indicates a potential ...
Ticker Report
9 months ago
Krystal Biotech (NASDAQ:KRYS Get Rating) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research note issued on Thursday, Zacks.com reports. The firm presently has a $71.00 price target on the stock. Zacks Investment Research&#...
Frequently Asked Questions
Frequently Asked Questions
What is Krystal Biotech Inc share price today?
plus_minus_icon
Can Indians buy Krystal Biotech Inc shares?
plus_minus_icon
How can I buy Krystal Biotech Inc shares from India?
plus_minus_icon
Can Fractional shares of Krystal Biotech Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Krystal Biotech Inc stocks?
plus_minus_icon
What is today’s traded volume of Krystal Biotech Inc?
plus_minus_icon
What is today’s market capitalisation of Krystal Biotech Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Krystal Biotech Inc?
plus_minus_icon
What percentage is Krystal Biotech Inc down from its 52-Week High?
plus_minus_icon
What percentage is Krystal Biotech Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$80.36
$0.41
(0.51%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00